KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,714,616 | +335.2% | 75,126 | +340.5% | 0.00% | +200.0% |
Q2 2023 | $2,002,257 | +3.7% | 17,055 | -29.2% | 0.00% | 0.0% |
Q1 2023 | $1,929,926 | +552.0% | 24,106 | +434.6% | 0.00% | – |
Q2 2022 | $296,000 | -89.3% | 4,509 | -89.2% | 0.00% | – |
Q1 2022 | $2,777,000 | -60.2% | 41,727 | -58.2% | 0.00% | -100.0% |
Q4 2021 | $6,986,000 | +289.0% | 99,884 | +190.4% | 0.00% | +100.0% |
Q3 2021 | $1,796,000 | +187.8% | 34,400 | +230.6% | 0.00% | – |
Q4 2020 | $624,000 | +52.2% | 10,406 | +5.1% | 0.00% | – |
Q2 2020 | $410,000 | +70.1% | 9,900 | +42.7% | 0.00% | – |
Q3 2019 | $241,000 | – | 6,939 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |